XLO
#4272
Xilio Therapeutics, Inc. - Common Stock
9.2 4 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.98%
Monthly Change
+15.64%
6 month change
+1300.00%
Year Change
+1183.33%
Previous Close
9.1 5
Open
9.2 4
Low
9.2 4
High
9.2 4
Volume
1
Financials
- Market Capitalization 53.43 M
- Employee 76
- Founded 2016
- CEO N/A
- Website www.xiliotx.com
- Headquarter Delaware, United States
- FIGI BBG00M4D4X92
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.14
Price to sales ratio
3.42
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4258 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 1.33 USD | -7.64% | -22.22% | -16.88% | -40.09% | 54.69 M USD | ||
| 4268 |  MCRB Seres Therapeutics, Inc. - Common Stock | 5.62 USD | -8.02% | -26.54% | -3.44% | -31.71% | 53.87 M USD | ||
| 4284 |  TIL Instil Bio, Inc. - Common Stock | 7.64 USD | -0.78% | -0.78% | -3.90% | -60.80% | 51.81 M USD | ||
| 4288 |  MREO Mereo BioPharma Group plc - American Depositary Shares | 0.32 USD | -5.88% | 0.00% | +3.23% | -81.50% | 51.08 M USD |
Frequently asked questions about Xilio Therapeutics, Inc. - Common Stock
What is the Xilio Therapeutics, Inc. - Common Stock stock price today?
The current price of Xilio Therapeutics, Inc. - Common Stock (XLO) is 9.24. Over the past 24 hours, the stock has changed by +0.98%. Follow the XLO chart for real-time price dynamics.
What is the stock ticker of Xilio Therapeutics, Inc. - Common Stock?
Xilio Therapeutics, Inc. - Common Stock trades under the ticker XLO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Xilio Therapeutics, Inc. - Common Stock stock going up?
XLO has changed by -1.60% over the last week, +15.64% over the last month, and +1183.33% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Xilio Therapeutics, Inc. - Common Stock net income for the last quarter?
Xilio Therapeutics, Inc. - Common Stock reported net income of -9.53 M for the last quarter. The previous quarter showed 10.36 M, which means net income changed by -191.98%.
How many employees does Xilio Therapeutics, Inc. - Common Stock have?
As of the latest available data, Xilio Therapeutics, Inc. - Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.
What is Xilio Therapeutics, Inc. - Common Stock EBITDA?
Xilio Therapeutics, Inc. - Common Stock EBITDA is -13.77 M, and its EBITDA margin is -108.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Xilio Therapeutics, Inc. - Common Stock stock?
You can buy Xilio Therapeutics, Inc. - Common Stock (XLO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Xilio Therapeutics, Inc. - Common Stock stock?
Investing in Xilio Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XLO chart and related analysis on metatrader.com as part of your research.